SENZOLO, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.788
AS - Asia 7.407
EU - Europa 3.141
AF - Africa 1.189
SA - Sud America 1.107
Continente sconosciuto - Info sul continente non disponibili 227
OC - Oceania 107
Totale 25.966
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.056
SG - Singapore 2.331
CN - Cina 1.261
VN - Vietnam 1.155
HK - Hong Kong 797
BR - Brasile 651
IT - Italia 629
BD - Bangladesh 346
FI - Finlandia 303
DE - Germania 294
FR - Francia 251
IN - India 222
PL - Polonia 174
SE - Svezia 171
GB - Regno Unito 159
CA - Canada 133
NL - Olanda 106
RU - Federazione Russa 105
JP - Giappone 95
TR - Turchia 95
AR - Argentina 94
IQ - Iraq 88
PH - Filippine 83
MX - Messico 77
ES - Italia 74
ZA - Sudafrica 70
PK - Pakistan 67
AT - Austria 56
UA - Ucraina 56
VE - Venezuela 56
SA - Arabia Saudita 55
KR - Corea 53
CO - Colombia 51
BE - Belgio 50
TN - Tunisia 50
RO - Romania 49
EC - Ecuador 48
JM - Giamaica 48
PY - Paraguay 47
IE - Irlanda 46
ET - Etiopia 44
UZ - Uzbekistan 42
CI - Costa d'Avorio 41
ID - Indonesia 41
GR - Grecia 40
JO - Giordania 40
MY - Malesia 40
CR - Costa Rica 39
DO - Repubblica Dominicana 38
NP - Nepal 38
AZ - Azerbaigian 37
CL - Cile 37
EG - Egitto 37
KE - Kenya 37
PE - Perù 36
AE - Emirati Arabi Uniti 35
GA - Gabon 35
GH - Ghana 35
ML - Mali 35
IL - Israele 34
MA - Marocco 34
MD - Moldavia 34
KG - Kirghizistan 33
PR - Porto Rico 33
AL - Albania 32
BJ - Benin 32
GN - Guinea 32
MU - Mauritius 32
TZ - Tanzania 32
UY - Uruguay 32
CH - Svizzera 31
PA - Panama 31
SK - Slovacchia (Repubblica Slovacca) 31
TW - Taiwan 31
CD - Congo 30
CM - Camerun 30
CZ - Repubblica Ceca 30
GT - Guatemala 30
HU - Ungheria 30
LB - Libano 30
LC - Santa Lucia 30
MZ - Mozambico 30
TJ - Tagikistan 30
BF - Burkina Faso 29
CV - Capo Verde 29
CW - ???statistics.table.value.countryCode.CW??? 29
DZ - Algeria 29
ME - Montenegro 29
MN - Mongolia 29
SN - Senegal 29
TT - Trinidad e Tobago 29
BB - Barbados 28
HR - Croazia 28
PS - Palestinian Territory 28
ZW - Zimbabwe 28
BO - Bolivia 27
BS - Bahamas 27
EE - Estonia 27
GF - Guiana Francese 27
MG - Madagascar 27
Totale 24.512
Salva come PNG Salva come JPEG
Città #
San Jose 1.435
Ashburn 1.426
Singapore 1.415
Fairfield 1.208
Hong Kong 716
Woodbridge 699
Chandler 598
Houston 585
New York 555
Ann Arbor 495
Seattle 433
Cambridge 407
Wilmington 347
Ho Chi Minh City 338
Santa Clara 264
Los Angeles 249
Hanoi 248
Beijing 241
Boardman 194
Helsinki 182
San Diego 158
Princeton 135
Bytom 124
Lauterbourg 123
Medford 120
Des Moines 105
Dong Ket 104
Council Bluffs 85
Munich 82
Dallas 76
Da Nang 74
Padova 69
Roxbury 69
Chicago 68
Milan 68
Buffalo 67
Nanjing 61
São Paulo 61
Guangzhou 60
Jacksonville 51
Tokyo 50
London 49
Brooklyn 44
Montreal 43
Haiphong 42
Rome 42
Shanghai 41
Orem 40
San Francisco 39
Abidjan 38
Amman 38
Baghdad 37
Hefei 37
Addis Ababa 36
Istanbul 36
Phoenix 36
Tashkent 36
Johannesburg 35
Nairobi 35
Baku 34
Denver 34
Dublin 34
Libreville 33
Atlanta 32
Conakry 32
Nuremberg 31
Vienna 31
Accra 30
Bishkek 30
Cotonou 30
Dushanbe 30
Panama City 30
Toronto 30
Castries 29
Dakar 29
Shenyang 29
Ulan Bator 29
Villafranca Padovana 29
Bamako 28
Chennai 27
Nassau 27
San José 27
Turku 27
Warsaw 27
Bridgetown 26
Frankfurt am Main 26
Managua 26
Podgorica 26
Kingston 25
Kingstown 25
Tunis 25
Vientiane 25
Boston 24
Dar es Salaam 24
Harare 24
Maputo 24
Nouakchott 24
Tianjin 24
Amsterdam 23
Antananarivo 23
Totale 15.692
Salva come PNG Salva come JPEG
Nome #
Liver transplantation for viral hepatitis in 2015 615
Therapeutic approaches for portal biliopathy: A systematic review 424
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial 342
The animal naming test: An easy tool for the assessment of hepatic encephalopathy 333
Endothelial damage of the portal vein is associated with Heparin-like effect in advanced stages of cirrhosis 300
Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience. 297
Markers of acute rejection and graft acceptance in liver transplantation. 286
Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation - a multicenter cohort study 282
18F-fluorodeoxyglucose positron emission tomography study of brain metabolism in cirrhosis: effect of liver transplantation 278
Predictive value of induced hyperammonaemia and neuropsychiatric profiling in relation to the occurrence of post-TIPS hepatic encephalopathy 278
Short-term outcomes of pediatric liver transplant recipients after transition to Adult Healthcare Service 277
Cavoportal hemitransposition associated to portoportal anastomosis for liver transplant in portomesenteric thrombosis. 275
Baveno VII – Renewing consensus in portal hypertension 267
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis: results of a randomized controlled clinical trial 260
Liver Fibrosis and Steatosis in Alstrom Syndrome: A Genetic Model for Metabolic Syndrome 260
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals. 259
Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data 259
Obliterative portal venopathy without portal hypertension: An underestimated condition 258
Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features 254
Who Fares Worse After Liver Transplantation? Impact of Donor and Recipient Variables on Outcome: Data from a Prospective Study. 249
Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure 249
Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma 246
Management of portal hypertension severe complications 244
Perioperative thrombotic complications in liver transplantation 241
HCV eradication is not associated with drop-out due to HCC progression in patients awaiting liver transplantation: A monocentric experience 241
USE OF ANTI-HBc POSITIVE DONORS IN LIVER TRANSPLANTATION: THE EXPERIENCE OF PADUA LIVER TRANSPLANT CENTRE 241
Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites 237
A Longitudinal, Prospective Study On Adherence To Medical Regimen Before and After Liver Transplantation 236
A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis 235
Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy 230
Non Adherence To Medical Prescriptions In Liver Transplantation: A Prospective Longitudinal Study 228
Cyanoacrylate injection to treat recurrent bleeding from Dieulafoy's lesion. 227
Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis 227
More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC 227
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study 225
Geotrichum capitatum Invasive Infection Early After Liver Transplant 223
Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study 222
Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis 220
Neuropsychological alterations in hepatitis C infection: the role of inflammation. 220
Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis 220
Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosis. 219
A prospective longitudinal assessment of de novo metabolic syndrome after liver transplantation 217
Does decreased fibrinolysis have a role to play in the development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis? 216
Current and future perspective on targeted agents and immunotherapies in hepatocellular carcinoma 213
PERIPHERAL NK CELLS IN PATIENTS WITH HCV RECURRENCE AFTER LIVER TRANSPLANTATION DURING INTERFERON-FREE ANTIVIRAL THERAPY 211
Whole blood rotation thromboelastometry (ROTEM®) profiles in subjects with non-neoplastic portal vein thrombosis. 209
Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy 209
Predictors of Response To Anticoagulant Therapy For the Treatment of Portal Vein Thrombosis (pvt) In Cirrhosis Patients 208
Determinants of increased thrombotic tendency in NASH cirrhosis: not there yet! 208
Local prothrombotic state in portal venous system in cirrhosis 205
Eradication of HCV in patients awaiting liver transplantation does not increase drop-out due to HCC progression 203
A Prioritization Model for Liver Transplantation Based on a Dual Waiting List: A Prospective Controlled Study 199
Outcome of critically ill cirrhotic patients admitted to the ICU: The role of ACLF 199
Biodegradable Biliary Stents for Percutaneous Treatment of Post-liver Transplantation Refractory Benign Biliary Anastomotic Strictures 199
Drug induced liver injury: from pathogenesis to liver transplantation 199
Reply to "Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis" 199
Influence of hepatocellular carcinoma on platelet aggregation in cirrhosis 198
Fibrosis Progression in Non Responders to Antiviral Treatment (AT) in HCV Recurrence Following Liver Transplantation (LT): An Italian Multicenter Retrospective Study 194
Antibiotic therapy for spontaneous bacterial peritonitis in acute-on-chronic liver failure: Handle with care 194
Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis 193
Does Once-Daily Tacrolimus (Advagraf) Increase Adherence to Immunosuppressive Therapy in Liver Transplanted Patients? 192
Prioritization Tools To Predict Short and Long Term Mortality Following Liver Transplantation 190
Management of Severe Bleeding in Liver Disease and Transplantation 190
Outcome of a First Episode of Bacterial Infection in Candidates for Liver Transplantation 189
Malnourished cirrhotic patient: what should we do? 189
Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death 189
Drop-out rate due to HCC progression is not affected by HCV eradication with DAAs in patients awaiting liver transplantation 188
Normal cortical regional cerebral blood flow justifies the normal neuropsychological performance in patients with cholestatic liver disease 182
Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections 182
New indications for liver transplantation 181
Orthotopic Liver Transplantation in Alcoholic Liver Disease Patients 180
New insights into the coagulopathy of liver disease and liver transplantation 179
Hypnotic Hallucination of Body Heating Modifies Splanchnic Circulation: Haemodynamic and Ultrasonographic Pilot Study in Normal Volunteers 179
Hepatitis C virus and liver transplantation: Where do we stand? 176
Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting 176
Severity of systemic inflammation is the main predictor of ACLF and bleeding in patients with acutely decompensated cirrhosis 175
Managment of Nonneoplastic Portal Vein Thrombosis in the Setting of Liver Trasplantation: a Systematic Review 172
Self-Reported Adherence to Medical Prescriptions before and after Liver Transplantation: A Longitudinal Study 169
Beneficial role of terlipressin in decompensated cirrhotics with spontaneous bacterial peritonitis 169
Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection 169
Corrigendum to ‘Baveno VII – Renewing consensus in portal hypertension’ [J Hepatol (2022) 959-974] 165
Effect of Low Molecular Weight Heparin (lmwh) On Thrombin Generation In Cirrhotic Patients At Different Stages of Liver Disease 163
Role of local endothelial alterations in the pathogenesis of portal vein thrombosis in cirrhosis 163
Anticoagulation for portal vein thrombosis in cirrhotic patients should be always considered 163
Lack of agreement for defining 'clinical suspicion of rejection' in liver transplantation: a model to select candidates for liver biopsy. 162
Successful pregnancy in Alagille Syndrome. 160
Recurrent facial dyskinesias due to extrapontine myelinolysis 159
Milestones in the discovery of Budd-Chiari syndrome 159
Acute Cellular Rejection in Liver Transplanted Patients: Incidence, Risk Factors, and Impact on Outcome 158
Staging the pre-procedural prophylaxis in decompensated cirrhosis 157
Interventional treatment should be incorporated in the algorithm for the management of patients with portal vein thrombosis 156
Management of the critically ill patient with cirrhosis: A multidisciplinary perspective 155
Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis 155
A Commentary on the Interplay Between Severity of Liver Disease and Bacterial Infection in Hospitalized Patients with Cirrhosis 155
Evaluation of intestinal barrier function and histologic aspects "in vivo" and its normalization after beta-blocker treatment in patients with cirrhosis and portal hypertension 153
Increased thrombin generation in liver transplant recipients: does immunosuppressive therapy play a role? 151
Acute Allograft Rejection After Liver Transplantation: Incidence, Risk Factors and Impact On Outcome 149
Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinoma 147
Haemostatic alterations in patients with cirrhosis and hepatocellular carcinoma: laboratory evidence and clinical implications 146
Use of grafts from Anti-HBc-positive donors in liver transplantation: A 5-year, single-center experience 145
Totale 21.521
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.115
article - articoli 75.225
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 514
Totale 153.854
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.679 0 177 218 106 72 185 99 157 67 86 154 358
2022/20231.269 238 120 37 130 226 146 19 97 152 11 84 9
2023/2024870 41 146 100 76 79 103 72 30 28 53 69 73
2024/20253.221 2 241 156 123 379 92 163 242 320 109 566 828
2025/202613.629 581 957 1.672 2.006 1.106 1.006 2.014 1.015 1.523 711 583 455
2026/2027752 650 102 0 0 0 0 0 0 0 0 0 0
Totale 25.966